NewsTradingSentimentCalendarCommunityBriefing
Sign in
Stocks LIVE

Guardant Health Q2 Revenue Surges 44% Amid Peer Beat

By Stocks Desk · 2026-09-16 · Updated 2026-09-16 18:58 UTC
A glass vial containing a small sample of red liquid resting on a white laboratory bench
Illustration: Tradingbird

Guardant Health's Q2 results saw revenue surge 44% to $335 million with raised guidance, marking it as the top performer in its sector with the biggest analyst estimate beat and strongest growth trajectory compared to peers.

  • New peer comparisons from GN stocks/nasdaq confirm Guardant Health posted the largest revenue beat, fastest growth, and most aggressive guidance raise among five tracked testing and diagnostics firms, outperforming rivals like RadNet and Labcorp.

    Source: Yahoo Finance

  • Guardant Health delivered its strongest quarter yet, with liquid biopsy revenue growing 44.3% and full-year guidance raised significantly above consensus.

    Source: Yahoo Finance UK
Based on reporting by Yahoo Finance UK and Yahoo Finance, compiled by the Tradingbird desk.

Read next

More in Stocks
A sterile surgical instrument tray with stainless steel tools arranged neatly on a white cloth
Stocks · Healthcare

Solventum Q2 Revenue Beats Estimates

Solventum reported Q2 revenue of $2.21 billion, exceeding analyst expectations by 2.5% and outperforming peers in the surgical equipment sector.

2026-09-16Illustration: Tradingbird
A stethoscope resting on a wooden desk next to a closed laptop
Stocks · Healthcare

Teladoc Q2 Revenue Misses Estimates, Shares Drop 28%

Teladoc Health posted a 4% year-over-year revenue decline, missing analyst forecasts and signaling weak future growth.

2026-09-16Illustration: Tradingbird
A modern hospital corridor with glass doors and soft lighting
Stocks · Healthcare

Evolent Health Q2 Revenue Surges 46.9% to Lead Peer Group

Evolent Health delivered the strongest quarter among tracked healthcare technology providers, with revenue growth far outpacing peers and a significant upgrade to full-year financial outlooks.

2026-09-16Illustration: Tradingbird

More from the Stocks desk

All desk stories